Switzerland· 56275004
Angeliq
A drospirenon und estrogen product containing drospirenonum, estradiolum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 8 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Drospirenon und estrogen is registered in 8 of 19 countries.
Countries holding a registration under ATC G03FA17 (drospirenon und estrogen), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 5 of them publish a price we can compare per daily dose
Drospirenon und estrogen · ATC G03FA17
8 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Ireland
- Italyprice
- Netherlands
- Switzerlandprice
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- drospirenonum, estradiolum
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- G03FA17
- ATC class
- Drospirenon und Estrogen
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin76805627500443x 28 StkCHF 49.75
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
12 interactions on record for drospirenon und estrogen.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Drospirenon und estrogen · interactions on record
12 records
12 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Drospirenon und estrogen in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandAllureneBayer Schering Pharma Oy
- GermanyAngeliqBayer Vital Gmbh
- SpainANGELIQ 1 mg/2 mg COMPRIMIDOS RECUBIERTOS CON PELICULABayer Hispania S.L.
- United StatesAngeliqBayer HealthCare Pharmaceuticals Inc.
- United KingdomAngeliq 1mg/2mg tabletsBayer Plc
- ItalyANGELIQBAYER S.P.A.
- NetherlandsAngeliq, 1 mg/2 mg filmomhulde tablettenBayer B.V.
- PolandAngeliqBayer AG
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Belgium · Angeliq, Klimedix
- Czechia · Angeliq, Paosonelle
- Germany · Angeliq, Klimedix
- Estonia · Angeliq
- Spain · Angeliq
- Finland · Angeliq
- Croatia · Angeliq
- Ireland · Angeliq
- Italy · Angeliq, Paosonelle
- Lithuania · Angeliq
- Luxembourg · Angeliq
- Latvia · Angeliq, Klimedix
- Malta · Angeliq
- Netherlands · Angeliq, Paosonelle
- Poland · Angeliq
- Portugal · Angeliq, Klimedix
- Slovenia · Angeliq
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/51ce8014-cb26-4cdd-b6fb-34083c009bf3 GET /v1/drugs/51ce8014-cb26-4cdd-b6fb-34083c009bf3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "drospirenonum 2 mg + estradiolum 1 mg",
"valid_from": "2007-05-01",
"limitations": null,
"galenic_form": "Filmtabl",
"therapeutic_area": null,
"sl_inclusion_date": "2007-05-01",
"self_retention_pct": 10
}See everything about drospirenon und estrogen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.